BOOTHBAY FUND MANAGEMENT, LLC - IMMUNOGEN INC ownership

IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 189 filers reported holding IMMUNOGEN INC in Q3 2019. The put-call ratio across all filers is 0.21 and the average weighting 0.0%.

Quarter-by-quarter ownership
BOOTHBAY FUND MANAGEMENT, LLC ownership history of IMMUNOGEN INC
ValueSharesWeighting
Q3 2023$18,626,397
+30.9%
1,173,686
+55.6%
0.44%
+42.0%
Q2 2023$14,234,603
+17303.4%
754,351
+3441.6%
0.31%
+15500.0%
Q1 2023$81,792
-96.7%
21,300
-95.7%
0.00%
-96.5%
Q4 2022$2,473,552
-18.3%
498,700
-6.6%
0.06%
-32.1%
Q3 2021$3,027,000
+2487.2%
534,000
+2001.5%
0.08%
+950.0%
Q2 2020$117,000
+41.0%
25,410
+5.0%
0.01%
+14.3%
Q1 2020$83,000
+6.4%
24,200
-33.0%
0.01%0.0%
Q2 2019$78,000
-2.5%
36,095
+22.9%
0.01%
-12.5%
Q1 2019$80,00029,3700.01%
Other shareholders
IMMUNOGEN INC shareholders Q3 2019
NameSharesValueWeighting ↓
TWIN FOCUS CAPITAL PARTNERS, LLC 140,000$2,090,0002.48%
BB BIOTECH AG 3,165,816$47,266,0002.44%
SECTORAL ASSET MANAGEMENT INC 3,623,786$54,103,0002.22%
Lumbard & Kellner, LLC 81,225$1,192,0001.02%
Artal Group S.A. 1,300,000$19,409,0000.70%
SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) 100,000$1,493,0000.48%
Rhenman & Partners Asset Management AB 73,702$1,100,0000.33%
PINNACLE ASSOCIATES LTD 883,647$13,193,0000.26%
FIRST TRUST ADVISORS LP 3,608,918$53,881,0000.24%
Granahan Investment Management 540,641$8,072,0000.22%
View complete list of IMMUNOGEN INC shareholders